Logotipo do repositório
 

Publicação:
Preparation and Characterization of Amylose Inclusion Complexes for Drug Delivery Applications

dc.contributor.authorCarbinatto, Fernanda M. [UNESP]
dc.contributor.authorRibeiro, Tatiana S.
dc.contributor.authorColnago, Luiz Alberto
dc.contributor.authorEvangelista, Raul Cesar [UNESP]
dc.contributor.authorCury, Beatriz S. F. [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUniversidade Federal de São Carlos (UFSCar)
dc.contributor.institutionEmpresa Brasileira de Pesquisa Agropecuária (EMBRAPA)
dc.date.accessioned2018-11-26T16:56:26Z
dc.date.available2018-11-26T16:56:26Z
dc.date.issued2016-01-01
dc.description.abstractAmylose complexes with nimesulide (NMS) and praziquantel (PZQ) were prepared by a simple and low cost method, so that high yield (>57%) and drug content (up to 68.16%) were achieved. The influence of drug: polymer ratio, temperature, and presence of palmitic acid on the complexes properties was evaluated. Differential scanning calorimetry, X-ray diffraction, and nuclear magnetic resonance data evidenced the drug-polymer interaction and the formation of inclusion complexes with semi-crystalline structures related to type II complexes. The drug release rates from complexes were lowered in acid media (pH 1.2) and phosphate buffer (pH 6.9). The presence of pancreatin promoted a significant acceleration of the release rates of both drugs, evidencing the enzymatic degradability of these complexes. The highest enzymatic resistance of PZQ1:30PA60 degrees C complex makes the release time longer and the full release of PZQ in phosphate buffer with pancreatin occurred at 240 min, whereas the complexes with NMS and PZQ1:5PA90 degrees C did it in 60 min. According to the Weibull model, the drug release process in media without enzyme occurred by complex mechanisms involving diffusion, swelling, and erosion. In media containing pancreatin, generally, the better correlation was with the first order, evidencing the acceleration of the release rates of drugs in the early stages of the test, due to enzymatic degradation. (C) 2016 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.en
dc.description.affiliationSao Paulo State Univ, Sch Pharmaceut Sci, Grad Program Pharmaceut Sci, Araraquara, SP, Brazil
dc.description.affiliationSao Paulo State Univ, Sch Pharmaceut Sci, Dept Drugs & Pharmaceut, Araraquara, SP, Brazil
dc.description.affiliationUniv Fed Sao Carlos, DCNME, Sao Carlos, SP, Brazil
dc.description.affiliationEmbrapa Instrumentacao, Sao Carlos, SP, Brazil
dc.description.affiliationUnespSao Paulo State Univ, Sch Pharmaceut Sci, Grad Program Pharmaceut Sci, Araraquara, SP, Brazil
dc.description.affiliationUnespSao Paulo State Univ, Sch Pharmaceut Sci, Dept Drugs & Pharmaceut, Araraquara, SP, Brazil
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.format.extent231-241
dc.identifierhttp://dx.doi.org/10.1002/jps.24702
dc.identifier.citationJournal Of Pharmaceutical Sciences. Hoboken: Wiley-blackwell, v. 105, n. 1, p. 231-241, 2016.
dc.identifier.doi10.1002/jps.24702
dc.identifier.issn0022-3549
dc.identifier.urihttp://hdl.handle.net/11449/161837
dc.identifier.wosWOS:000381768000029
dc.language.isoeng
dc.publisherWiley-Blackwell
dc.relation.ispartofJournal Of Pharmaceutical Sciences
dc.relation.ispartofsjr0,984
dc.rights.accessRightsAcesso abertopt
dc.sourceWeb of Science
dc.subjectinclusion complexes
dc.subjecthigh amylose
dc.subjectnimesulide
dc.subjectpraziquantel
dc.subjectcontrolled release
dc.subjectsolid state NMR
dc.subjectX-ray diffractometry
dc.subjectcalorimetry (DSC)
dc.subjectdissolution
dc.titlePreparation and Characterization of Amylose Inclusion Complexes for Drug Delivery Applicationsen
dc.typeArtigopt
dcterms.licensehttp://olabout.wiley.com/WileyCDA/Section/id-406071.html
dcterms.rightsHolderWiley-Blackwell
dspace.entity.typePublication
relation.isDepartmentOfPublicatione214da1b-9929-4ae9-b8fd-655e9bfeda4b
relation.isDepartmentOfPublication.latestForDiscoverye214da1b-9929-4ae9-b8fd-655e9bfeda4b
unesp.departmentFármacos e Medicamentos - FCFpt

Arquivos